Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Christian Moctezuma Meza"'
Autor:
Nicolás Ramírez-Torres, María Eugenia Ayala-Anzures, Kenia Ortiz-Rodríguez, Ancizar Pérez-Puentes, Christian Moctezuma-Meza, Rosalia Victoria-Ayala, Larissa Antonieta Valenzuela-Martínez
Publikováno v:
Cirugia y cirujanos. 87(1)
To assess the pathological complete response (pCR) rate after neoadjuvant chemotherapy (NC) with anthracyclines with or without taxanes in management of locally advanced breast cancer (LABC).Patients with LABC were included. A cohort received four cy
Autor:
Christian Moctezuma Meza, María de Lourdes Muñoz, Juan Carlos Hinojosa-Cruz, Normand García-Hernández, Ashael Perez-Muñoz, Eduardo Domínguez-de-la-Cruz
Publikováno v:
Gene. 761:145047
Mitochondrial DNA (mtDNA) copy number and mitochondrial DNA haplogroups have been associated with different types of cancer, including breast cancer, because they alter cellular energy metabolism. However, whether mtDNA copy number or haplogroups are
Autor:
Germán Castelazo-Rico, Alberto Cedro-Tanda, Alejandro Monsalvo-Reyes, Alejandro Córdova-Solis, Emmanuel Pina-Jiménez, Normand García-Hernández, Marta Elena Hernández-Caballero, Christian Moctezuma-Meza, Alejandro Gómez-Delgado, Teresa Juárez-Cedillo, Fabio Salamanca-Gómez, Diego Arenas-Aranda
Publikováno v:
BMC Cancer
Background Breast cancer is a complex multifactorial genetic disease. Among other factors, race and, to an even greater extent, viruses are known to influence the development of this heterogeneous disease. It has been reported that MMTV-like (HMTV) g
Autor:
Alex Daniel, Mamani-Cancino, Maria Guadalupe, Veloz-Martínez, Ivonne, Casasola-Busteros, Christian, Moctezuma-Meza, Juan Manuel, García-Cebada
Publikováno v:
Ginecologia y obstetricia de Mexico. 82(6)
Her-2/neu is an oncogen related with a poor prognosis and high agresivity when overexpressed in breast cancer. Main objective was analyze the frecuency of positivity or negativity ofller/neu in patients with breast cancer after surgery and their rela
Autor:
Larissa Antonieta Valenzuela-Martínez, Germán Castelazo-Rico, Horacio Astudillo-de la Vega, Fidel Navarro-Muñoz, Nicolás Ramírez-Torres, Gilberto Tena-Alavez, Rosalia Victoria-Ayala, María Eugenia Ayala-Anzures, Rosa María Patlán-Pérez, Juan Asbun-Bojalil, Christian Moctezuma-Meza, Kenia Ortiz-Rodríguez
Publikováno v:
Gaceta Mexicana de Oncología. (1):3-12
ResumenObjetivoEstudio retrospectivo diseñado para evaluar la efectividad y tolerabilidad de docetaxel secuencial a epirrubicina como tratamiento sistémico neoadyuvante (TSN) en mujeres con cáncer de mama localmente avanzado.Pacientes y métodosPa